收稿日期: 2019-05-28
网络出版日期: 2019-06-25
基金资助
国家重点研发计划(2016YFC0901102);国家科技部重点研发计划(2017YFC1309701);国家科技部重点研发计划(2017YFC1309700);国家自然科学基金(81570029);上海重中之重临床重点学科建设项目(2017ZZ02014);上海高水平地方高校创新团队
周敏, 张秋蕊 . 呼吸道、肠道微生物菌群对慢性阻塞性肺疾病的发病及治疗的影响[J]. 诊断学理论与实践, 2019 , 18(03) : 246 -249 . DOI: 10.16150/j.1671-2870.2019.03.002
[1] | Dickson RP, Erb-Downward JR, Martinez FJ, et al. The Microbiome and the Respiratory Tract[J]. Annu Rev Physiol, 2016, 78:481-504. |
[2] | Hilty M, Burke C, Pedro H, et al. Disordered microbial communities in asthmatic airways[J]. PLoS One, 2010, 5(1):e8578. |
[3] | Erb-Downward JR, Thompson DL, Han MK, et al. Analysis of the lung microbiome in the "healthy" smoker and in COPD[J]. PLoS One, 2011, 6(2):e16384. |
[4] | Cabrera-Rubio R, Garcia-Nú? ez M, Setó L, et al. Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease[J]. J Clin Microbiol, 2012, 50(11):3562-3568. |
[5] | Mammen MJ, Sethi S. COPD and the microbiome[J]. Respirology, 2016, 21(4):590-599. |
[6] | Huang YJ, Kim E, Cox MJ, et al. A persistent and diverse airway microbiota present during chronic obstructive pulmonary disease exacerbation[J]. OMICS, 2010, 14(1):9-59. |
[7] | Millares L, Ferrari R, Gallego M, et al. Bronchial microbiome of severe COPD patients colonised by Pseudomonas aeruginosa[J]. Eur J Clin Microbiol Infect Dis, 2014, 33(7):1101-1111. |
[8] | Molyneaux PL, Mallia P, Cox MJ, et al. Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2013, 188(10):1224-1231. |
[9] | Wang Z, Bafadhel M, Haldar K, et al. Lung microbiome dynamics in COPD exacerbations[J]. Eur Respir J, 2016, 47(4):1082-1092. |
[10] | Huang YJ, Sethi S, Murphy T, et al. Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease[J]. J Clin Microbiol, 2014, 52(8):2813-2823. |
[11] | Sze MA, Dimitriu PA, Suzuki M, et al. Host Response to the Lung Microbiome in Chronic Obstructive Pulmonary Disease[J]. Am J Respir Crit Care Med, 2015, 192(4):438-445. |
[12] | Charlson ES, Chen J, Custers-Allen R, et al. Disordered microbial communities in the upper respiratory tract of cigarette smokers[J]. PLoS One, 2010, 5(12):e15216. |
[13] | Morris A, Beck JM, Schloss PD, et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers[J]. Am J Respir Crit Care Med, 2013, 187(10):1067-1075. |
[14] | Benjamin JL, Hedin CR, Koutsoumpas A, et al. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota[J]. Inflamm Bowel Dis, 2012, 18(6):1092-1100. |
[15] | Biedermann L, Brülisauer K, Zeitz J, et al. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH[J]. Inflamm Bowel Dis, 2014, 20(9):1496-1501. |
[16] | Kabeerdoss J, Jayakanthan P, Pugazhendhi S, et al. Alterations of mucosal microbiota in the colon of patients with inflammatory bowel disease revealed by real time polymerase chain reaction amplification of 16S ribosomal ribonucleic acid[J]. Indian J Med Res, 2015, 142(1):23-32. |
[17] | Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing[J]. Nature, 2010, 464(7285):59-65. |
[18] | Budden KF, Gellatly SL, Wood DL, et al. Emerging pathogenic links between microbiota and the gut-lung axis[J]. Nat Rev Microbiol, 2017, 15(1):55-63. |
[19] | Pistiner M, Gold DR, Abdulkerim H, et al. Birth by cesarean section, allergic rhinitis, and allergic sensitization among children with a parental history of atopy[J]. J Allergy Clin Immunol, 2008, 122(2):274-279. |
[20] | Chung KF. Airway microbial dysbiosis in asthmatic patients: A target for prevention and treatment?[J]. J Allergy Clin Immunol, 2017, 139(4):1071-1081. |
[21] | He Y, Wen Q, Yao F, et al. Gut-lung axis: The microbial contributions and clinical implications[J]. Crit Rev Microbiol, 2017, 43(1):81-95. |
[22] | Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease[J]. N Engl J Med, 2008, 359(22):2355-2365. |
[23] | Garmendia J, Morey P, Bengoechea JA. Impact of cigarette smoke exposure on host-bacterial pathogen interactions[J]. Eur Respir J, 2012, 39(2):467-477. |
[24] | Barnes PJ. Inflammatory endotypes in COPD[J]. Pharmacol Rev, 2004, 56(4):515-548. |
[25] | Miyata R, van Eeden SF. The innate and adaptive immune response induced by alveolar macrophages exposed to ambient particulate matter[J]. Toxicol Appl Pharmacol, 2011, 257(2):209-226. |
[26] | Rylance J, Kankwatira A, Nelson DE, et al. Household air pollution and the lung microbiome of healthy adults in Malawi: a cross-sectional study[J]. BMC Microbiol, 2016, 16(1): 182. |
[27] | Winter SE, B?umler AJ. Dysbiosis in the inflamed intestine: chance favors the prepared microbe[J]. Gut Microbes, 2014, 5(1):71-73. |
[28] | Larsen JM, Musavian HS, Butt TM, et al. Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology[J]. Immunology, 2015, 144(2):333-342. |
[29] | Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA[J]. Nature, 2000, 408(6813):740-745. |
[30] | Hartmann G, Krieg AM. Mechanism and function of a newly identified CpG DNA motif in human primary B cells[J]. J Immunol, 2000, 164(2):944-953. |
[31] | Kant R, de Vos WM, Palva A, et al. Immunostimulatory CpG motifs in the genomes of gut bacteria and their role in human health and disease[J]. J Med Microbiol, 2014, 63(Pt 2):293-308. |
[32] | Reale M, Boscolo P, Bellante V, et al. Daily intake of Lactobacillus casei Shirota increases natural killer cell activity in smokers[J]. Br J Nutr, 2012, 108(2):308-314. |
[33] | Sabra W, Kim EJ, Zeng AP. Physiological responses of Pseudomonas aeruginosa PAO1 to oxidative stress in controlled microaerobic and aerobic cultures[J]. Microbiology, 2002, 148(Pt 10):3195-3202. |
[34] | Tomoda K, Kubo K, Dairiki K, et al. Whey peptide-based enteral diet attenuated elastase-induced emphysema with increase in short chain fatty acids in mice[J]. BMC Pulm Med, 2015, 15:64. |
[35] | Hauptmann M, Schaible UE. Linking microbiota and respiratory disease[J]. FEBS Lett, 2016, 590(21):3721-3738. |
/
〈 |
|
〉 |